Integrated molecular characterization of myeloid neoplasms and identification of prognostic and therapeutic biomarkers

The project aims to further investigate the molecular characterization of myeloid neoplasms through an integrated approach combining molecular biology techniques, next-generation sequencing (NGS), and bioinformatic analyses, with the aim of identifying genetic alterations of interest and evaluating their relationship with the clinical phenotype, drug sensibility and disease evolution.